CHEMPACIFIC CORP

Overview

CHEMPACIFIC CORP is an active pharmaceutical ingredient (API) supplier with 16 active FDA Type II Drug Master Files, covering BENDAMUSTINE HYDROCHLORIDE; BGP32269; BUSULFAN DRUG SUBSTANCE; CARMUSTINE DRUG SUBSTANCE; CH011 (ACITRETIN) DRUG SUBSTANCE; CHP010 DRUG SUBSTANCE.

API / Drug Master Files

CHEMPACIFIC CORP holds 16 active (17 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• GS22264 DRUG SUBSTANCEActive2022-02-11
• V091015 DRUG SUBSTANCEActive2016-02-19
• BGP32269Active2009-11-01
• JSP92476 DRUG SUBSTANCEActive2009-06-02
• CARMUSTINE DRUG SUBSTANCEActive2009-03-20
• BENDAMUSTINE HYDROCHLORIDEActive2009-03-13
• JLP080574 DRUG SUBSTANCEActive2009-02-20
• CH011 (ACITRETIN) DRUG SUBSTANCEActive2008-02-25
• BUSULFAN DRUG SUBSTANCEActive2007-12-12
• PROCARBAZINE HYDROCHLORIDE (DRUG SUBSTANCE)Active2007-09-24
• CHP010 DRUG SUBSTANCEActive2007-07-09
• CHPO16 DRUG SUBSTANCEActive2007-05-21
• MELPHALAN DRUG SUBSTANCEActive2006-12-20
• DYCLONINE HYDROCHLORIDE DRUG SUBSTANCEActive2006-03-31
• PENTOSTATINActive2005-03-30

Showing 15 of 17 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHEMPACIFIC CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.